Press "Enter" to skip to content

New patent expiration for Bayer Hlthcare drug BEYAZ

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Bayer Hlthcare drug BEYAZ

Annual Drug Patent Expirations for BEYAZ
Annual Drug Patent Expirations for BEYAZ

Beyaz is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and two Paragraph IV challenges.

BEYAZ drug price trends.

Drug patent litigation for BEYAZ.

This drug has one hundred and six patent family members in forty countries.

The generic ingredient in BEYAZ is drospirenone; ethinyl estradiol; levomefolate calcium. Two suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol; levomefolate calcium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Bayer Hlthcare drug BEYAZ
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions